Charles River Opens Pre-Clinical Labs in Shanghai


Charles River Laboratories International (NYSE:CRL), a Wilmington, MA-based provider of drug development services, announced the opening of a 60,000-square-foot pre-clinical facility in Shanghai. The company says that the facility is intended to support the global drug-development needs of its clients.

By posting a comment, you agree to our terms and conditions.